Skip to content

DEARGEN UPDATES

Technical & News Articles about Deargen

Press Enter / Return to begin your search.
NEWS2021년 6월 2일2021년 8월 11일

Deargen Adds Former Hanmi Pharmaceutical “Dr. Inhwan Bae” as CDO

▲배인환 최고개발책임자(CDO)

Deargen, a company specializing in artificial intelligence (AI) drug development, announced on the 2nd that it adds Dr. Bae In-hwan, who was the research director of Hanmi Pharmaceutical’s synthetic new drug team, as the chief development officer (CDO).

Lead More →

이 글 공유하기:

  • 트위터
  • Facebook

이것이 좋아요:

좋아하기 가져오는 중...
Posted in NEWS and Tagged @language:english @Updates href:http://www.biospectator.com/view/news_view.php?varAtcId=13305

글 내비게이션

Previous article
Previous articleNEWS디어젠, 前한미약품 ‘배인환 박사’ CDO로 영입​
Next article
Next articleNEWS디어젠-이플라스크, AI활용 신약개발 공동연구 협약 체결
%d 블로거가 이것을 좋아합니다: